Guidelines of care for the management of primary cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 65, Issue 5, 2011, Pages 1032-1047

  Bichakjian, Christopher K ^a   Halpern, Allan C ^b   Johnson, Timothy M ^a   Foote Hood, Antoinette ^c   Grichnik, James M ^d   Swetter, Susan M ^e,f   Tsao, Hensin ^g   Barbosa, Victoria Holloway ^h   Chuang, Tsu Yi ^i,j   Duvic, Madeleine ^k   Ho, Vincent C ^l   Sober, Arthur J ^g   Beutner, Karl R ^m,n   Bhushan, Reva ^o   Smith Begolka, Wendy ^o  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j Desert Oasis Healthcare   (United States)

^k University of Texas Health Science Center at Houston   (United States)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ Solano Dermatology Associates   (United States)

^o AMERICAN ACADEMY OF DERMATOLOGY   (United States)

more..

Author keywords

biopsy; follow up; melanoma; pathology report; sentinel lymph node biopsy; surgical margins

Indexed keywords

IMIQUIMOD; LACTATE DEHYDROGENASE;

ADIPOSE TISSUE; AGE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; COMPUTER ASSISTED TOMOGRAPHY; CRYOSURGERY; DISTANT METASTASIS; EPILUMINESCENCE MICROSCOPY; EVIDENCE BASED MEDICINE; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE DISSECTION; LYMPHOCYTE; LYMPHOSCINTIGRAPHY; MALIGNANT LENTIGO; MELANOCYTIC HYPERPLASIA; MELANOMA; MICROMETASTASIS; MITOSIS; NAIL DISEASE; NEUROTROPISM; OFF LABEL DRUG USE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; SATELLITOSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT PLANNING; TUMOR BIOPSY;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; ASYMPTOMATIC DISEASES; CRYOTHERAPY; DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; LYMPHATIC METASTASIS; MELANOMA; NAIL DISEASES; NEOPLASM GRADING; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 80054113553     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.04.031     Document Type: Article

References (143)

1. D.G. Coit, R. Andtbacka, C.K. Bichakjian, R.A. Dilawari, D. Dimaio, and V. Guild Melanoma J Natl Compr Canc Netw 7 2009 250 275
2. J.R. Marsden, J.A. Newton-Bishop, L. Burrows, M. Cook, P.G. Corrie, and N.H. Cox Revised UK guidelines for the management of cutaneous melanoma 2010 Br J Dermatol 163 2010 238 256
3. Australian Cancer Network, New Zealand Guidelines Group, Cancer Council Australia, New Zealand Ministry of Health. Clinical practice guidelines for the management of melanoma in Australia and New Zealand: evidence-based best practice guidelines 2008 Australian Cancer Network Sydney, N.S.W.
4. M.H. Ebell, J. Siwek, B.D. Weiss, S.H. Woolf, J.L. Susman, and B. Ewigman Simplifying the language of evidence to improve patient care: strength of recommendation taxonomy (SORT); a patient-centered approach to grading evidence in medical literature J Fam Pract 53 2004 111 120
5. A.J. Sober, T.Y. Chuang, M. Duvic, E.R. Farmer, J.M. Grichnik, and A.C. Halpern Guidelines of care for primary cutaneous melanoma J Am Acad Dermatol 45 2001 579 586
6. C.M. Balch, J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.B. Atkins, and D.R. Byrd Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
7. C.M. Balch, J.E. Gershenwald, M.B. Atkins, A.C. Buzaid, N. Cascinelli, and A.J. Cochran Chapter 31. Melanoma of the skin S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti, AJCC cancer staging manual 2009 Springer New York 325 344
8. V.H. Stell, H.J. Norton, K.S. Smith, J.C. Salo, and R.L. White Jr. Method of biopsy and incidence of positive margins in primary melanoma Ann Surg Oncol 14 2007 893 898
9. D.J. Karimipour, J.L. Schwartz, T.S. Wang, C.K. Bichakjian, J.S. Orringer, and A.L. King Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma J Am Acad Dermatol 52 2005 798 802
10. J.R. Austin, R.M. Byers, W.D. Brown, and P. Wolf Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck Head Neck 18 1996 107 117
11. J.C. Ng, S. Swain, J.P. Dowling, R. Wolfe, P. Simpson, and J.W. Kelly The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service Arch Dermatol 146 2010 234 239
12. R.J. Pariser, A. Divers, and A. Nassar The relationship between biopsy technique and uncertainty in the histopathologic diagnosis of melanoma Dermatol Online J 5 1999 4
13. P.C. Ng, D.A. Barzilai, S.A. Ismail, R.L. Averitte Jr., and A.C. Gilliam Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth? J Am Acad Dermatol 48 2003 420 424
14. K. Armour, S. Mann, and S. Lee Dysplastic nevi: to shave, or not to shave? A retrospective study of the use of the shave biopsy technique in the initial management of dysplastic nevi Australas J Dermatol 46 2005 70 75
15. J.L. Bong, R.M. Herd, and J.A. Hunter Incisional biopsy and melanoma prognosis J Am Acad Dermatol 46 2002 690 694
16. J.S. Lederman, and A.J. Sober Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol 13 1985 983 987
17. V.C. Lees, and J.C. Briggs Effect of initial biopsy procedure on prognosis in stage 1 invasive cutaneous malignant melanoma: review of 1086 patients Br J Surg 78 1991 1108 1110
18. R.C. Martin II, C.R. Scoggins, M.I. Ross, D.S. Reintgen, R.D. Noyes, and M.J. Edwards Is incisional biopsy of melanoma harmful? Am J Surg 190 2005 913 917
19. D.S. Rigel, R. Friedman, and A.W. Kopf Surgical margins for the removal of dysplastic nevi J Dermatol Surg Oncol 11 1985 745
20. R. Corona, M. Scio, A. Mele, G. Ferranti, S. Mostaccioli, and V. Macchini Survival and prognostic factors in patients with localized cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy Eur J Cancer 30A 1994 333 338
21. E. Mansson-Brahme, J. Carstensen, K. Erhardt, B. Lagerlof, U. Ringborg, and L.E. Rutqvist Prognostic factors in thin cutaneous malignant melanoma Cancer 73 1994 2324 2332
22. L. Schuchter, D.J. Schultz, M. Synnestvedt, B.J. Trock, D. Guerry, and D.E. Elder A prognostic model for predicting 10-year survival in patients with primary melanoma: the pigmented lesion group Ann Intern Med 125 1996 369 375
23. A.C. Halpern, and L.M. Schuchter Prognostic models in melanoma Semin Oncol 24 1997 S2 S7
24. P.A. Gimotty, D. Guerry, M.E. Ming, R. Elenitsas, X. Xu, and B. Czerniecki Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging J Clin Oncol 22 2004 3668 3676
25. D. Massi, A. Franchi, L. Borgognoni, U.M. Reali, and M. Santucci Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression Cancer 85 1999 1067 1076
26. A.B. Francken, H.M. Shaw, J.F. Thompson, S.J. Soong, N.A. Accortt, and M.F. Azzola The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up Ann Surg Oncol 11 2004 426 433
27. E. Nagore, V. Oliver, R. Botella-Estrada, S. Moreno-Picot, A. Insa, and J.M. Fortea Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis Melanoma Res 15 2005 169 177
28. U. Leiter, P.G. Buettner, T.K. Eigentler, and C. Garbe Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German Dermatological Society J Clin Oncol 22 2004 3660 3667
29. A.J. Cochran, D. Elashoff, D.L. Morton, and R. Elashoff Individualized prognosis for melanoma patients Hum Pathol 31 2000 327 331
30. C.M. Balch, S. Soong, M.I. Ross, M.M. Urist, C.P. Karakousis, and W.J. Temple Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): intergroup melanoma surgical trial Ann Surg Oncol 7 2000 87 97
31. F. Levi, L. Randimbison, C. La Vecchia, V.C. Te, and S. Franceschi Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland Int J Cancer 78 1998 315 319
32. S. Sahin, B. Rao, A.W. Kopf, E. Lee, D.S. Rigel, and R. Nossa Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model Cancer 80 1997 1426 1431
33. O. Straume, and L.A. Akslen Independent prognostic importance of vascular invasion in nodular melanomas Cancer 78 1996 1211 1219
34. J. Eldh, B. Boeryd, and L.E. Peterson Prognostic factors in cutaneous malignant melanoma in stage I: a clinical, morphological and multivariate analysis Scand J Plast Reconstr Surg 12 1978 243 255
35. W.H. Clark Jr., D.E. Elder, D.T. Guerry, L.E. Braitman, B.J. Trock, and D. Schultz Model predicting survival in stage I melanoma based on tumor progression J Natl Cancer Inst 81 1989 1893 1904
36. R.L. Barnhill, J. Katzen, A. Spatz, J. Fine, and M. Berwick The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma J Cutan Pathol 32 2005 268 273
37. R.L. Barnhill, J.A. Fine, G.C. Roush, and M. Berwick Predicting five-year outcome for patients with cutaneous melanoma in a population-based study Cancer 78 1996 427 432
38. A.A. Marghoob, K. Koenig, F.V. Bittencourt, A.W. Kopf, and R.S. Bart Breslow thickness and Clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging Cancer 88 2000 589 595
39. M.F. Azzola, H.M. Shaw, J.F. Thompson, S.J. Soong, R.A. Scolyer, and G.F. Watson Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
40. D. Massi, L. Borgognoni, A. Franchi, L. Martini, U.M. Reali, and M. Santucci Thick cutaneous malignant melanoma: a reappraisal of prognostic factors Melanoma Res 10 2000 153 164
41. T.K. Eigentler, P.G. Buettner, U. Leiter, and C. Garbe Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German central malignant melanoma registry J Clin Oncol 22 2004 4376 4383
42. T.F. Kimsey, T. Cohen, A. Patel, K.J. Busam, and M.S. Brady Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging Ann Surg Oncol 16 2009 1176 1183
43. L. Shaikh, R.W. Sagebiel, C.M. Ferreira, M. Nosrati, J.R. Miller III, and M. Kashani-Sabet The role of microsatellites as a prognostic factor in primary malignant melanoma Arch Dermatol 141 2005 739 742
44. U.N. Rao, J. Ibrahim, L.E. Flaherty, J. Richards, and J.M. Kirkwood Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690 J Clin Oncol 20 2002 2053 2057
45. S.C. Paek, K.A. Griffith, T.M. Johnson, V.K. Sondak, S.L. Wong, and A.E. Chang The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma Cancer 109 2007 100 108
46. M. Thorn, R. Bergstrom, M. Hedblad, B. Lagerlof, U. Ringborg, and H.O. Adami Predictors of late mortality in cutaneous malignant melanoma-a population-based study in Sweden Int J Cancer 67 1996 38 44
47. C.G. Clemente, M.C. Mihm Jr., R. Bufalino, S. Zurrida, P. Collini, and N. Cascinelli Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1996 1303 1310
48. J.M. Taran, and P.J. Heenan Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis Cancer 91 2001 1822 1825
49. K.W. Anderson, S.R. Baker, L. Lowe, L. Su, and T.M. Johnson Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique Arch Facial Plast Surg 3 2001 202 206
50. H. Demirci, T.M. Johnson, B.R. Frueh, D.C. Musch, D.R. Fullen, and C.C. Nelson Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure Ophthalmology 115 2008 2295-300e3
51. W.G. Hawkins, K.J. Busam, L. Ben-Porat, K.S. Panageas, D.G. Coit, and D.E. Gyorki Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma Ann Surg Oncol 12 2005 207 213
52. T.M. Pawlik, M.I. Ross, V.G. Prieto, M.T. Ballo, M.M. Johnson, and P.F. Mansfield Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma Cancer 106 2006 900 906
53. T.S. Wang, T.M. Johnson, P.N. Cascade, B.G. Redman, V.K. Sondak, and J.L. Schwartz Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma J Am Acad Dermatol 51 2004 399 405
54. G.B. Fogarty, and C. Tartaguia The utility of magnetic resonance imaging in the detection of brain metastases in the staging of cutaneous melanoma Clin Oncol (R Coll Radiol) 18 2006 360 362
55. E.P. Miranda, M. Gertner, J. Wall, E. Grace, M. Kashani-Sabet, and R. Allen Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease Arch Surg 139 2004 831 837
56. J. Hafner, M.H. Schmid, W. Kempf, G. Burg, W. Kunzi, and C. Meuli-Simmen Baseline staging in cutaneous malignant melanoma Br J Dermatol 150 2004 677 686
57. M. Yancovitz, N. Finelt, M.A. Warycha, P.J. Christos, M. Mazumdar, and R.L. Shapiro Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma Cancer 110 2007 1107 1114
58. U. Hofmann, M. Szedlak, W. Rittgen, E.G. Jung, and D. Schadendorf Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival Br J Cancer 87 2002 151 157
59. M.H. Terhune, N. Swanson, and T.M. Johnson Use of chest radiography in the initial evaluation of patients with localized melanoma Arch Dermatol 134 1998 569 572
60. D.J. Brenner, and E.J. Hall Computed tomography-an increasing source of radiation exposure N Engl J Med 357 2007 2277 2284
61. B. Singh, S. Ezziddin, H. Palmedo, M. Reinhardt, H. Strunk, and T. Tuting Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma Melanoma Res 18 2008 346 352
62. E.C. Starritt, R.F. Uren, R.A. Scolyer, M.J. Quinn, and J.F. Thompson Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma Ann Surg Oncol 12 2005 18 23
63. I.A. Ho Shon, D.K. Chung, R.P. Saw, and J.F. Thompson Imaging in cutaneous melanoma Nucl Med Commun 29 2008 847 876
64. M.L. Bafounta, A. Beauchet, S. Chagnon, and P. Saiag Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis Lancet Oncol 5 2004 673 680
65. B. Krug, R. Crott, M. Lonneux, J.F. Baurain, and A.S. Pirson Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review Radiology 249 2008 836 844
66. L. Machet, F. Nemeth-Normand, B. Giraudeau, A. Perrinaud, J. Tiguemounine, and J. Ayoub Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocenter cohort study of 373 patients Br J Dermatol 152 2005 66 70
67. T.A. Aloia, J.E. Gershenwald, R.H. Andtbacka, M.M. Johnson, C.W. Schacherer, and C.S. Ng Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma J Clin Oncol 24 2006 2858 2865
68. J.S. Gold, D.P. Jaques, K.J. Busam, M.S. Brady, and D.G. Coit Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy Ann Surg Oncol 14 2007 2133 2140
69. P.K. Pandalai, F.J. Dominguez, J. Michaelson, and K.K. Tanabe Clinical value of radiographic staging in patients diagnosed with AJCC stage III melanoma Ann Surg Oncol 18 2011 506 513
70. A.C. Buzaid, L. Tinoco, M.I. Ross, S.S. Legha, and R.S. Benjamin Role of computed tomography in the staging of patients with local-regional metastases of melanoma J Clin Oncol 13 1995 2104 2108
71. T.M. Johnson, D.J. Fader, A.E. Chang, A. Yahanda, J.W. Smith II, and K.R. Hamlet Computed tomography in staging of patients with melanoma metastatic to the regional nodes Ann Surg Oncol 4 1997 396 402
72. B.W. Kuvshinoff, C. Kurtz, and D.G. Coit Computed tomography in evaluation of patients with stage III melanoma Ann Surg Oncol 4 1997 252 258
73. L.A. DiFronzo, L.A. Wanek, R. Elashoff, and D.L. Morton Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma Ann Surg Oncol 6 1999 705 711
74. C.R. Ferrone, L. Ben Porat, K.S. Panageas, M. Berwick, A.C. Halpern, and A. Patel Clinicopathological features of and risk factors for multiple primary melanomas JAMA 294 2005 1647 1654
75. A.B. Francken, N.A. Accortt, H.M. Shaw, M.H. Colman, M. Wiener, and S.J. Soong Follow-up schedules after treatment for malignant melanoma Br J Surg 95 2008 1401 1407
76. C. Garbe, A. Paul, H. Kohler-Spath, U. Ellwanger, W. Stroebel, and M. Schwarz Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 2003 520 529
77. W.B. Goggins, and H. Tsao A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors Cancer 97 2003 639 643
78. K.A. McCaul, L. Fritschi, P. Baade, and M. Coory The incidence of second primary invasive melanoma in Queensland, 1982-2003 Cancer Causes Control 19 2008 451 458
79. K.M. Dalal, A. Patel, M.S. Brady, D.P. Jaques, and D.G. Coit Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy Ann Surg Oncol 14 2007 1934 1942
80. A. Barth, L.A. Wanek, and D.L. Morton Prognostic factors in 1,521 melanoma patients with distant metastases J Am Coll Surg 181 1995 193 201
81. M.B. Atkins, M.T. Lotze, J.P. Dutcher, R.I. Fisher, G. Weiss, and K. Margolin High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 J Clin Oncol 17 1999 2105 2116
82. M.B. Atkins, J. Hsu, S. Lee, G.I. Cohen, L.E. Flaherty, and J.A. Sosman Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group J Clin Oncol 26 2008 5748 5754
83. R.A. Pollitt, A.C. Geller, D.R. Brooks, T.M. Johnson, E.R. Park, and S.M. Swetter Efficacy of skin self-examination practices for early melanoma detection Cancer Epidemiol Biomarkers Prev 18 2009 3018 3023
84. K. Moore Dalal, Q. Zhou, K.S. Panageas, M.S. Brady, D.P. Jaques, and D.G. Coit Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy Ann Surg Oncol 15 2008 2206 2214
85. H. Tsao, M. Feldman, J.E. Fullerton, A.J. Sober, D. Rosenthal, and W. Goggins Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival Arch Dermatol 140 2004 67 70
86. M. Weiss, C.L. Loprinzi, E.T. Creagan, R.J. Dalton, P. Novotny, and J.R. O'Fallon Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1995 1703 1705
87. R.L. Morton, J.C. Craig, and J.F. Thompson The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients Ann Surg Oncol 16 2009 571 577
88. C.M. Balch, S.J. Soong, J.E. Gershenwald, J.F. Thompson, D.S. Reintgen, and N. Cascinelli Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 2001 3622 3634
89. H.B. Neuman, A. Patel, N. Ishill, C. Hanlon, M.S. Brady, and A.C. Halpern A single-institution validation of the AJCC staging system for stage IV melanoma Ann Surg Oncol 15 2008 2034 2041
90. M.B. Lens, P. Nathan, and V. Bataille Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials Arch Surg 142 2007 885 893
91. U. Veronesi, and N. Cascinelli Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma Arch Surg 126 1991 438 441
92. U. Veronesi, N. Cascinelli, J. Adamus, C. Balch, D. Bandiera, and A. Barchuk Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm N Engl J Med 318 1988 1159 1162
93. D.B. McKenna, R.J. Lee, R.J. Prescott, and V.R. Doherty A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision Br J Dermatol 150 2004 523 530
94. N. Cascinelli Margin of resection in the management of primary melanoma Semin Surg Oncol 14 1998 272 275
95. U. Ringborg, R. Andersson, J. Eldh, B. Glaumann, L. Hafstrom, and S. Jacobsson Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish melanoma study group Cancer 77 1996 1809 1814
96. G. Cohn-Cedermark, L.E. Rutqvist, R. Andersson, M. Breivald, C. Ingvar, and H. Johansson Long term results of a randomized study by the Swedish melanoma study group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm Cancer 89 2000 1495 1501
97. D. Khayat, O. Rixe, G. Martin, C. Soubrane, M. Banzet, and J.A. Bazex Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick) Cancer 97 2003 1941 1946
98. J.M. Thomas, J. Newton-Bishop, R. A'Hern, G. Coombes, M. Timmons, and J. Evans Excision margins in high-risk malignant melanoma N Engl J Med 350 2004 757 766
99. C.M. Balch, S.J. Soong, T. Smith, M.I. Ross, M.M. Urist, and C.P. Karakousis Long-term results of a prospective surgical trial comparing 2 cm vs 4 cm excision margins for 740 patients with 1-4 mm melanomas Ann Surg Oncol 8 2001 101 108
100. C.P. Karakousis, C.M. Balch, M.M. Urist, M.M. Ross, T.J. Smith, and A.A. Bartolucci Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial Ann Surg Oncol 3 1996 446 452
101. C.M. Balch, M.M. Urist, C.P. Karakousis, T.J. Smith, W.J. Temple, and K. Drzewiecki Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial Ann Surg 218 1993 262 269
102. K.M. Heaton, J.J. Sussman, J.E. Gershenwald, J.E. Lee, D.S. Reintgen, and P.F. Mansfield Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma Ann Surg Oncol 5 1998 322 328
103. G.M. Bricca, D.G. Brodland, D. Ren, and J.A. Zitelli Cutaneous head and neck melanoma treated with Mohs micrographic surgery J Am Acad Dermatol 52 2005 92 100
104. N.I. Bene, C. Healy, and B.M. Coldiron Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases Dermatol Surg 34 2008 660 664
105. C. Hazan, S.W. Dusza, R. Delgado, K.J. Busam, A.C. Halpern, and K.S. Nehal Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases J Am Acad Dermatol 58 2008 142 148
106. H.W. Walling, R.K. Scupham, A.K. Bean, and R.I. Ceilley Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma J Am Acad Dermatol 57 2007 659 664
107. V.G. Prieto, Z.B. Argenyi, R.L. Barnhill, P.H. Duray, R. Elenitsas, and L. From Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol 120 2003 203 208
108. U.V. Buettiker, N.Y. Yawalkar, L.R. Braathen, and R.E. Hunger Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients Arch Dermatol 144 2008 943 945
109. M.A. Cotter, J.K. McKenna, and G.M. Bowen Treatment of lentigo maligna with imiquimod before staged excision Dermatol Surg 34 2008 147 151
110. M.F. Naylor, N. Crowson, R. Kuwahara, K. Teague, C. Garcia, and C. Mackinnis Treatment of lentigo maligna with topical imiquimod Br J Dermatol 149 Suppl 2003 66 70
111. A.M. Powell, A.M. Robson, R. Russell-Jones, and R.J. Barlow Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up Br J Dermatol 160 2009 994 998
112. M.L. Spenny, J. Walford, A.E. Werchniak, V. Beltrani, J.B. Brennick, and C.A. Storm Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports Cutis 79 2007 149 152
113. M.H. Schmid-Wendtner, B. Brunner, B. Konz, P. Kaudewitz, C.M. Wendtner, and R.U. Peter Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients J Am Acad Dermatol 43 2000 477 482
114. R.W. Tsang, F.F. Liu, W. Wells, and D.G. Payne Lentigo maligna of the head and neck: results of treatment by radiotherapy Arch Dermatol 130 1994 1008 1012
115. A. Farshad, G. Burg, R. Panizzon, and R. Dummer A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays Br J Dermatol 146 2002 1042 1046
116. A.R. Harwood Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma Int J Radiat Oncol Biol Phys 9 1983 1019 1021
117. E.G. Kuflik, and A.A. Gage Cryosurgery for lentigo maligna J Am Acad Dermatol 31 1994 75 78
118. P. Collins, S. Rogers, M. Goggin, and W. Manning Cryotherapy for lentigo maligna Clin Exp Dermatol 16 1991 433 435
119. K. Bohler-Sommeregger, S. Schuller-Petrovic, R. Neumann, and E. Muller Cryosurgery of lentigo maligna Plast Reconstr Surg 90 1992 436 444
120. R.P. Dawber, and J.D. Wilkinson Melanotic freckle of Hutchinson: treatment of macular and nodular phases with cryotherapy Br J Dermatol 101 1979 47 49
121. S.A. Zacarian Cryosurgical treatment of lentigo maligna Arch Dermatol 118 1982 89 92
122. D.L. Morton, J.F. Thompson, R. Essner, R. Elashoff, S.L. Stern, and O.E. Nieweg Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial; multicenter selective lymphadenectomy trial group Ann Surg 230 1999 453 465
123. J. Mattsson, L. Bergkvist, A. Abdiu, J.F. Aili Low, P. Naredi, and K. Ullberg Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005 Acta Oncol 47 2008 1519 1525
124. C.R. Rossi, G.L. De Salvo, G. Trifiro, S. Mocellin, G. Landi, and G. Macripo The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian multicentric study (SOLISM-IMI) J Nucl Med 47 2006 234 241
125. A. Testori, G.L. De Salvo, M.C. Montesco, G. Trifiro, S. Mocellin, and G. Landi Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI) Ann Surg Oncol 16 2009 2018 2027
126. D.L. Morton, A.J. Cochran, J.F. Thompson, R. Elashoff, R. Essner, and E.C. Glass Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg 242 2005 302 313
127. T.M. Johnson, V.K. Sondak, C.K. Bichakjian, and M.S. Sabel The role of sentinel lymph node biopsy for melanoma: evidence assessment J Am Acad Dermatol 54 2006 19 27
128. W.G. Stebbins, L. Garibyan, and A.J. Sober Sentinel lymph node biopsy and melanoma: 2010 update, part I J Am Acad Dermatol 62 2010 723 734 quiz 35-6
129. W.G. Stebbins, L. Garibyan, and A.J. Sober Sentinel lymph node biopsy and melanoma: 2010 update, part II J Am Acad Dermatol 62 2010 737 748 quiz 49-50
130. J.E. Gershenwald, P.F. Mansfield, J.E. Lee, and M.I. Ross Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma Ann Surg Oncol 7 2000 160 165
131. C.R. Ferrone, K.S. Panageas, K. Busam, M.S. Brady, and D.G. Coit Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status Ann Surg Oncol 9 2002 637 645
132. M.S. Sabel, K.A. Griffith, A. Arora, J. Shargorodsky, D.G. Blazer III, and R. Rees Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy Surgery 141 2007 728 735
133. D.L. Morton, J.F. Thompson, A.J. Cochran, N. Mozzillo, R. Elashoff, and R. Essner Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317
134. T.P. Kingham, K.S. Panageas, C.E. Ariyan, K.J. Busam, M.S. Brady, and D.G. Coit Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy Ann Surg Oncol 17 2010 514 520
135. Z.I. Nowecki, P. Rutkowski, and W. Michej The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3) Ann Surg Oncol 15 2008 2223 2234
136. S.L. Wong, D.L. Morton, J.F. Thompson, J.E. Gershenwald, S.P. Leong, and D.S. Reintgen Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study Ann Surg Oncol 13 2006 809 816
137. R.J. Bleicher, R. Essner, L.J. Foshag, L.A. Wanek, and D.L. Morton Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas J Clin Oncol 21 2003 1326 1331
138. J.M. Ranieri, J.D. Wagner, S. Wenck, C.S. Johnson, and J.J. Coleman III The prognostic importance of sentinel lymph node biopsy in thin melanoma Ann Surg Oncol 13 2006 927 932
139. M.A. Warycha, J. Zakrzewski, Q. Ni, R.L. Shapiro, R.S. Berman, and A.C. Pavlick Meta-analysis of sentinel lymph node positivity in thin melanoma (
140. S.L. Wong, M.W. Kattan, K.M. McMasters, and D.G. Coit A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system Ann Surg Oncol 12 2005 282 288
141. B.E. Wright, R.P. Scheri, X. Ye, M.B. Faries, R.R. Turner, and R. Essner Importance of sentinel lymph node biopsy in patients with thin melanoma Arch Surg 143 2008 892 900
142. C. Gajdos, K.A. Griffith, S.L. Wong, T.M. Johnson, A.E. Chang, and V.M. Cimmino Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 115 2009 5752 5760
143. R. Gutzmer, I. Satzger, K.M. Thoms, B. Volker, C. Mitteldorf, and A. Kapp Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas J Dtsch Dermatol Ges 6 2008 198 203